Anzeige
Mehr »
Login
Donnerstag, 23.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
InnoCan Pharma: Jetzt in die Doppel-Chance investieren?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A401UY | ISIN: US36151G6008 | Ticker-Symbol: 12Q0
Lang & Schwarz
23.05.24
18:32 Uhr
2,250 Euro
-2,250
-100,00 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
INTELLIGENT BIO SOLUTIONS INC Chart 1 Jahr
5-Tage-Chart
INTELLIGENT BIO SOLUTIONS INC 5-Tage-Chart
RealtimeGeldBriefZeit
2,2102,29018:32
0,0000,00008:00

Aktuelle News zur INTELLIGENT BIO SOLUTIONS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
14:36Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Unveils Key Performance Indicator Growth in the United Kingdom as Drug Screening Industry Combats Drug Test Cheating and Searches for Simpler, Faster, Non-Invasive and More Cost-Effective ... 1
DiXFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 21.05.2024459The following instruments on Boerse Frankfurt do have their last trading day on 21.05.2024.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 21.05.2024.ISIN NameCA00379L1067 ABRASILV....
► Artikel lesen
MoINTELLIGENT BIO SOLUTIONS INC. - 8-K, Current Report1
FrIntelligent Bio Solutions, Inc.: Innovative Fingerprint Drug Screening Solution Showcased at the UK's Premier Health and Safety Event3
08.05.Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Inc. Reports Fiscal 2024 Third Quarter and Nine-Month Financial Results and Operational Highlights89Year-over-year revenue increased 80% for the fiscal third quarter and 193% for the nine months ended March 31, 2024 Cash and cash equivalents as of March 31, 2024, was $9.40 million Commenced FDA...
► Artikel lesen
08.05.INTELLIGENT BIO SOLUTIONS INC. - 10-Q, Quarterly Report3
03.05.INTELLIGENT BIO SOLUTIONS INC. - 8-K, Current Report3
18.04.INTELLIGENT BIO SOLUTIONS INC. - 8-K, Current Report4
18.04.Intelligent Bio Solutions reports Preliminary Unaudited Fiscal Q3 results3
18.04.Intelligent Bio Solutions expects approximate unaudited Q3 revenue of $0.82M3
18.04.Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Inc. Announces Preliminary Unaudited Fiscal Third Quarter and Nine-Month Revenue Results450NEW YORK, April 18, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing...
► Artikel lesen
11.04.Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Subsidiary Broadens Intellectual Property Portfolio with Grant of New European Patent with Unitary Effect for Innovative Intelligent Fingerprinting DSR-Plus Cartridge Reader6
09.04.INTELLIGENT BIO SOLUTIONS INC. - 8-K, Current Report5
05.04.Looking Into Intelligent Bio Solutions' Recent Short Interest2
26.03.Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions to Present at the LD Micro Invitational XIV Investor Conference on April 9 in NYC9
13.03.Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Announces Closing of $10.1 Million Private Placement Priced At-the-Market Under Nasdaq Rules10
11.03.Intelligent Bio Solutions Announces $10.1 Mln Private Placement2
11.03.Intelligent BIO Ekes up on Private Placement8
11.03.Intelligent Bio Solutions secures $10.1 million in private placement4
11.03.Intelligent Bio Solutions announces $10M private placement priced at-the-market under Nasdaq rules2
Seite:  Weiter >>
61 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,5